ArticleFrontiers in immunology2023

Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma.

Simona Secondino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.